S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Repros Holds Constructive Meeting With FDA Regarding Androxal(R) NDA Filing|
|Alkermes’ New Drug Application for Aripiprazole Lauroxil for Treatment of Schizophrenia Accepted for Filing by U.S. FDA|
|ACADIA Pharmaceuticals Reports Third Quarter 2014 Financial Results and Updates Timing of NUPLAZID™ NDA Submission|
|Actavis Announces FDA Acceptance for Filing of NDA for Eluxadoline|
|Alexion Submits NDA in Japan for Asfotase Alfa as a Treatment for Patients with Hypophosphatasia|
|Sarepta Therapeutics Announces Regulatory Update on Eteplirsen|
|Avanir Pharmaceuticals Announces Preliminary Feedback from the FDA on AVP-825 for the Acute Treatment of Migraine|
|BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of Third Quarter 2014 Financials|
|Prosensa Announces 3rd Quarter 2014 Financial Results and Recent Corporate Developments (2014/11/17)|
|Prosensa Announces 2nd Quarter 2014 Financial Results and Recent Corporate Developments (2014/8/12)|
Click above to view more mutual fund data and stats for nda - Aurubis AG.